Literature DB >> 24670845

Protein concentration and mitochondrial content in the gastrocnemius predicts mortality rates in patients with peripheral arterial disease.

J R Thompson1, S A Swanson, G Haynatzki, P Koutakis, J M Johanning, P R Reppert, E Papoutsi, D Miserlis, Z Zhu, G P Casale, I I Pipinos.   

Abstract

OBJECTIVE: This study evaluated the hypothesis that protein concentration and mitochondrial content in gastrocnemius biopsies from patients with peripheral arterial disease (PAD) predict mortality rates.
BACKGROUND: PAD patients experience advancing myopathy characterized by mitochondrial dysfunction, myofiber degradation, and fibrosis in their ischemic legs, along with increased mortality rates.
METHODS: Samples from the gastrocnemius of PAD patients were used for all analyses. Protein concentration was normalized to muscle wet weight, and citrate synthase activity (standard measure of mitochondrial content in cells) was normalized to muscle wet weight and protein concentration. Protein and citrate synthase data were grouped into tertiles and 5-year, all-cause mortality for each tertile was determined with Kaplan-Meier curves and compared by the modified Peto-Peto test. A Cox-regression model for each variable controlled for the effects of clinical characteristics.
RESULTS: Of the 187 study participants, 46 died during a mean follow-up of 23.0 months. Five-year mortality rate was highest for patients in the lowest tertile of protein concentration. Mortality was lowest for patients in the middle tertile of citrate synthase activity when normalized to either muscle wet weight or protein concentration. The mortality hazard ratios (HRs) from the Cox analysis were statistically significant for protein concentration normalized to muscle wet weight (lowest vs middle tertile; HR = 2.93; P = 0.008) and citrate synthase normalized to protein concentration (lowest vs middle tertile; HR = 4.68; P = 0.003; and lowest vs highest tertile; HR = 2.36; P = 0.027).
CONCLUSIONS: Survival analysis of a contemporaneous population of PAD patients identifies protein and mitochondrial content of their gastrocnemius as predictors of mortality rate.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24670845     DOI: 10.1097/SLA.0000000000000643

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

Review 1.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

2.  Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.

Authors:  Panagiotis Koutakis; Dimitrios Miserlis; Sara A Myers; Julian Kyung-Soo Kim; Zhen Zhu; Evlampia Papoutsi; Stanley A Swanson; Gleb Haynatzki; Duy M Ha; Lauren A Carpenter; Rodney D McComb; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Histochem Cytochem       Date:  2015-01-09       Impact factor: 2.479

3.  Muscle strength and control characteristics are altered by peripheral artery disease.

Authors:  Molly N Schieber; Ryan M Hasenkamp; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou; Holly K DeSpiegelaere; Jung H Chien; Sara A Myers
Journal:  J Vasc Surg       Date:  2017-07       Impact factor: 4.268

4.  Peripheral artery disease affects the function of the legs of claudicating patients in a diffuse manner irrespective of the segment of the arterial tree primarily involved.

Authors:  Todd J Leutzinger; Panagiotis Koutakis; Matthew A Fuglestad; Hafizur Rahman; Holly Despiegelaere; Mahdi Hassan; Molly Schieber; Jason M Johanning; Nick Stergiou; G Matthew Longo; George P Casale; Sara A Myers; Iraklis I Pipinos
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

5.  An endovascular model of ischemic myopathy from peripheral arterial disease.

Authors:  Chandler A Long; Lucas H Timmins; Panagiotis Koutakis; Traci T Goodchild; David J Lefer; Iraklis I Pipinos; George P Casale; Luke P Brewster
Journal:  J Vasc Surg       Date:  2016-09-29       Impact factor: 4.268

6.  Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.

Authors:  Terence E Ryan; Cameron A Schmidt; Rick J Alleman; Alvin M Tsang; Thomas D Green; P Darrell Neufer; David A Brown; Joseph M McClung
Journal:  J Mol Cell Cardiol       Date:  2016-06-01       Impact factor: 5.000

7.  Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Authors:  Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung
Journal:  JCI Insight       Date:  2018-11-02

8.  Effect of limb demand ischemia on autophagy and morphology in mice.

Authors:  Hassan Albadawi; Rahmi Oklu; John D Milner; Thuy P Uong; Hyung-Jin Yoo; William G Austen; Michael T Watkins
Journal:  J Surg Res       Date:  2015-04-09       Impact factor: 2.192

9.  Synthesis and characterization of a hyaluronic acid-based hydrogel with antioxidative and thermosensitive properties.

Authors:  Meng Chen; Cui Li; Fujiao Nie; Xiaoyan Liu; Iraklis I Pipinos; Xiaowei Li
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

10.  Impaired microcirculatory function, mitochondrial respiration, and oxygen utilization in skeletal muscle of claudicating patients with peripheral artery disease.

Authors:  Song-Young Park; Elizabeth J Pekas; Cody P Anderson; Tyler N Kambis; Paras K Mishra; Molly N Schieber; TeSean K Wooden; Jonathan R Thompson; Kyung Soo Kim; Iraklis I Pipinos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.